SELLAS LIFE SCIENCES GROUP I
SLS·81642T209·US·Common Stock·Healthcare - Biotechnology-13D/G
SLS (SELLAS LIFE SCIENCES GROUP I) is held by 87 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($51.6M), STATE STREET CORP ($35.5M), VANGUARD CAPITAL MANAGEMENT LLC ($31.8M). Net institutional sentiment: Bullish.
87
Holders
Avg rating(24 Elite)
$213.1M
Total Value
81% (94)
Fund Consensus
74 buying - 17 selling
Who's Trading
ActivistANAnson Funds Management LP4.9%Feb 17, 2026
ActivistHIHighbridge Capital Management, LLC3.7%Jan 30, 2026
InsiderKBKalin Katherine BachBuy $101KNov 19, 2025
InsiderVLVAN NOSTRAND ROBERT LBuy $15KJun 12, 2025
InsiderWJWasman JaneBuy $34KMay 30, 2025
InsiderKBKalin Katherine BachBuy $36KMay 22, 2025
13F: Insider & Congress:
Showing 1-20 of 94
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer